It was demonstrated that LeftyA has an effect on inhibiting proliferation and activation of apoptotic cascades, and therefore is considered a suitable anti-tumor agent [104]; it specifically acts negatively on Na+/H+ exchanger 1 (NHE1) activity [105]. Here, SLC9A1 is linked to neoplasm.